Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall
March 14, 2024 at 16:15 PM EDT
Spruce Biosciences Inc(NASDAQ:SPRB) shares plummeted on Thursday after the company released topline results from its CAHmelia-203 ...